Kalium Phosphoricum 3 DH • Mercurius solubilis hahnemanni 8 DH • Natrium Nitricum 3 DH • Natrum Sulfuricum 2 DH • Potassium Iodide 4 DH • Sodium Tetrachloroaurate dihydrate 8 DH. Other Ingredients: Lactose Monohydrate, Magnesium Stearate, Rice Starch.
Brand name products often contain multiple ingredients. To read detailed information about each ingredient, click on the link for the individual ingredient shown above.
In 2004, Canada began regulating natural medicines as a category of products separate from foods or drugs. These products are officially recognized as "Natural Health Products." These products include vitamins, minerals, herbal preparations, homeopathic products, probiotics, fatty acids, amino acids, and other naturally derived supplements.
In order to be marketed in Canada, natural health products must be licensed. In order to be licensed in Canada, manufacturers must submit applications to Health Canada including information about uses, formulation, dosing, safety, and efficacy.
Products can be licensed based on several criteria. Some products are licensed based on historical or traditional uses. For example, if an herbal product has a history of traditional use, then that product may be acceptable for licensure. In this case, no reliable scientific evidence is required for approval.
For products with non-traditional uses, some level of scientific evidence may be required to support claimed uses. However, a high level of evidence is not necessarily required. Acceptable sources of evidence include at least one well-designed, randomized, controlled trial; well-designed, non-randomized trials; cohort and case control studies; or expert opinion reports.
Finished products licensed by Health Canada must be manufactured according to Good Manufacturing Practices (GMPs) as outlined by Health Canada.
This is a homeopathic preparation. Homeopathy is a system of medicine established in the 19th century by a German physician named Samuel Hahnemann. Its basic principles are that "like treats like" and "potentiation through dilution." For example, in homeopathy, diarrhea would be treated with an extreme dilution of a substance that normally causes diarrhea when taken in high doses.
Practitioners of homeopathy believe that more dilute preparations are more potent. Many homeopathic preparations are so diluted that they contain little or no active ingredient. Therefore, most homeopathic products are not expected to have any pharmacological effects, drug interactions, or other harmful effects. Any beneficial effects are controversial and cannot be explained by current scientific methods.
Dilutions of 1 to 10 are designated by an "X." So a 1X dilution = 1:10, 3X=1:1000; 6X=1:1,000,000. Dilutions of 1 to 100 are designated by a "C." So a 1C dilution = 1:100; 3C = 1:1,000,000. Dilutions of 24X or 12C or more contain zero molecules of the original active ingredient.
Homeopathic products are permitted for sale in the US due to legislation passed in 1938 sponsored by a homeopathic physician who was also a Senator. The law still requires that the FDA allow the sale of products listed in the Homeopathic Pharmacopeia of the United States. However, homeopathic preparations are not held to the same safety and effectiveness standards as conventional medicines. For more information, see the Homeopathy monograph.
Below is general information about the effectiveness of the known ingredients contained in the product Throatypax Sublingual Tablet. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
There is insufficient reliable information available about the effectiveness of sodium tetrachloroaurate.
Below is general information about the safety of the known ingredients contained in the product Throatypax Sublingual Tablet. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
LIKELY SAFE ...when used orally and appropriately. Iodine is safe in amounts that do not exceed the tolerable upper intake level (UL) of 1100 mcg daily (7135,103070). Higher doses can be safely used with appropriate medical monitoring (2197,7080). In some regions of the world, such as Japan, daily dietary intake is estimated to be as high as 5,280-13,800 mcg without adverse outcomes (16747). ...when used topically and appropriately, as a 2% solution. A 2% iodine solution is an FDA-approved prescription product (15).
POSSIBLY UNSAFE ...when used orally in high doses. Tell patients to avoid prolonged use of doses exceeding the UL of 1100 mcg daily without proper medical supervision. There is concern that higher intake can increase the risk of side effects such as thyroid dysfunction, as well as thyroiditis, thyroid papillary cancer, thyrotoxicosis, and atrial fibrillation (7135,55962,56013). However, in some regions of the world such as Japan, daily dietary intake is estimated to be as high as 5,280-13,800 mcg without adverse outcomes (16747).
CHILDREN: LIKELY SAFE
when used orally and appropriately (7135).
Iodine is safe in amounts that do not exceed the tolerable upper intake level (UL) of 200 mcg daily for children 1-3 years, 300 mcg daily for children 4-8 years, 600 mcg daily for children 9-13 years, and 900 mcg daily for adolescents (7135). ...when used topically as a 2% solution (15). Iodine is an FDA-approved prescription product.
CHILDREN: POSSIBLY UNSAFE
when used orally in doses exceeding the UL (7135,108709).
Higher intake can cause thyroid dysfunction (7135) and may be associated with a modest reduction in intelligence (108709).
PREGNANCY AND LACTATION: LIKELY SAFE
when used orally and appropriately.
Iodine is safe in amounts that do not exceed the tolerable upper intake level (UL) of 1100 mcg daily in those 18 years and older or 900 mcg daily in those 14-18 years of age (7135,103070). Iodine needs increase during pregnancy and lactation and adequate intakes should begin as soon as a patient is aware of the pregnancy, or earlier in areas of potential deficiency (17920). ...when used topically as a 2% solution (15). Iodine is an FDA-approved prescription product.
PREGNANCY AND LACTATION: POSSIBLY UNSAFE
when used orally in doses exceeding the UL.
Higher intake can cause thyroid dysfunction (7135). Also, higher intakes during pregnancy cause increased iodine levels in breast milk and infant blood samples. Higher iodine intake during pregnancy has also been associated with an increased risk of congenital hypothyroidism and reduced mental and physical development in the offspring (56089,91390,91394,91395).
There is insufficient reliable information available about the safety of sodium tetrachloroaurate.
PREGNANCY: POSSIBLY UNSAFE
when used orally or parenterally.
Sodium tetrachloroaurate is a gold salt. Evidence from animal models shows that the administration of other gold salts increases the risk of miscarriage and congenital abnormalities in the offspring (100534). Theoretically, sodium tetrachloroaurate may have similar adverse effects; avoid using.
LACTATION:
Insufficient reliable information available; avoid using.
Sodium tetrachloroaurate is a gold salt. There is evidence that gold is excreted in milk following the administration of other oral and injectable gold salts (100534). It is unclear if sodium tetrachloroaurate is excreted in breastmilk or what the possible adverse effects may be. Until more is known, avoid using.
Below is general information about the interactions of the known ingredients contained in the product Throatypax Sublingual Tablet. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Combining iodine with amiodarone might cause excessively high iodine levels.
Details
|
Iodine might alter the effects of antithyroid drugs.
Details
|
Combining iodine with lithium might have additive hypothyroid effects.
Details
Lithium can inhibit thyroid function. Several case reports suggest that concomitant use of lithium and potassium iodide can reduce thyroid function in otherwise healthy adults (17574). Monitor thyroid function.
|
Below is general information about the adverse effects of the known ingredients contained in the product Throatypax Sublingual Tablet. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General
...Orally, iodine is well tolerated when taken in amounts that do not exceed the tolerable upper intake level (UL) or when used therapeutically with appropriate medical monitoring (2197,7080,7135).
Most Common Adverse Effects:
Orally: Abdominal upset, diarrhea, goiter, headache, hyperthyroidism, hypothyroidism, metallic taste, nausea, rhinorrhea, thyroid adenoma.
Topically: Burns, dermatitis, irritation.
Serious Adverse Effects (Rare):
All ROAs: Hypersensitivity reactions such as anaphylaxis and angioedema.
Dermatologic
...Orally, taking iodine chronically or in large amounts has been reported to cause acneform skin lesions called iododerma (2138).
In one case, a patient developed iododerma after consuming a specific product (Hoxsey's Brown Tonic) containing an unspecified quantity of potassium iodide. After several months of consumption, the patient developed acneform skin lesions on the nose, cheeks, and upper back and presented with a urine iodine level of 7,455,647 ug/L (reference range: 34-523 ug/L). After discontinuation of potassium iodide, the lesions resolved gradually over the course of several weeks (95431).
Topically, iodine may stain skin, irritate tissues, and cause sensitization in some individuals (15,56106). Iodine burns are associated with application of 7% hydroalcoholic solution (15). Povidone-iodine may cause contact dermatitis or irritant reactions in some people. However, patch testing with potassium iodide is usually negative in these patients, indicating that contact dermatitis caused by topical iodine does not indicate a propensity for reaction to oral potassium iodide (93001).
Endocrine
...Prolonged use and/or large oral doses of iodine intake can cause thyroid gland hyperplasia, thyroid adenoma, goiter, and hypothyroidism (15,56013,56089,91397,91398,99793,99795).
In another case report, an infant presented with reversible hypothyroidism at birth because the mother had consumed excessive seaweed soup during and after pregnancy, which resulted in excessive iodine consumption (99795). Iodine has also been linked to rare cases of adverse events. In one case report, a 56-year-old male developed thyrotoxic hypokalemic paralysis thought to be related to excessive intake of iodine (91401).
Topically, using povidone-iodine (PI) 1% solution as a gargle and nasal spray, in addition to intranasal application of PI 10% ointment over 5 days, can precipitate subclinical hypothyroidism, with elevated thyroid stimulating hormone (TSH) and normal thyroid hormone levels. TSH levels seem to normalize about 7-12 days after stopping topical PI application (105877).
Gastrointestinal
...Orally, the commonly reported adverse effects of a saturated solution of potassium iodide (SSKI) are nausea (14%), abdominal pain (14%), metallic taste (4%), and diarrhea (4%) (17561).
These side effects can be minimized by avoiding quick dosage increases (17574). Taking iodine chronically or in large amounts has also been reported to cause soreness in teeth and gums, burning in mouth and throat, increased salivation, swelling of parotid and submaxillary glands, inflammation of the respiratory tract, gastric upset, and diarrhea (15,2138).
Intranasally, applying povidone-iodine 1% solution along with a 10% ointment can cause unpleasant nasal tingling (105877).
Immunologic ...People who are allergic to iodine-containing foods or drugs are sometimes stated to have "iodine allergy", but the actual allergen is another agent such as seafood proteins or radiocontrast media (93001). However, some people can be hypersensitive to iodine when used orally. Symptoms of hypersensitivity can include angioedema, cutaneous and mucosal hemorrhage, fever, arthralgia, lymph node enlargement, eosinophilia, urticaria, erythema, and thrombotic thrombocytopenic purpura (15,17561). Other reported side effects include potassium toxicity, metabolic acidosis, pustular psoriasis, and vasculitis (17574). However, such sensitivity is very rare (93001). Orally, iodine hypersensitivity can cause fatal periarteritis (15).
Neurologic/CNS
...Orally, common side effects of a saturated solution of potassium iodide (SSKI) have included headache (7%) (17561).
Side effects can be minimized by avoiding quick dosage increases (17574).
High intake of iodine may be associated with adverse cognitive outcomes in children. Observational research in children aged 7-14 years has found that those consuming drinking water with iodine concentrations above 900 mcg/L daily, which exceeds the tolerable upper intake level, is associated with a 1.6-point reduction in intelligence level when compared with those consuming water with iodine concentrations below 300 mcg/L (108709).
Ocular/Otic ...Orally, taking iodine chronically or in large amounts has been reported to cause eye irritation and eyelid swelling (15,2138).
Pulmonary/Respiratory ...Orally, common side effects of a saturated solution of potassium iodide (SSKI) included rhinorrhea (11%) (17561). Side effects can be minimized by avoiding quick dosage increases (17574). Taking iodine chronically or in large amounts has also been reported to cause coryza, sneezing, cough, and pulmonary edema (15,2138). Ophthalmically, povidone-iodine 5% solution 3 drops administered in each eye has been reported to slow respiration by about 18 seconds (range 4 to 96 seconds) when compared with saline control in children ages 2-17 years undergoing strabismus surgery (103077).
Renal ...When povidone-iodine was used in renal pelvic instillation sclerotherapy, one patient (2%) had significant flank pain during treatment (55970).
General ...No adverse effects have been reported; however, a thorough evaluation of safety outcomes has not been conducted. Sodium tetrachloroaurate contains gold and might cause adverse effects similar to other gold salts. Orally, gold salts have been reported to cause gastrointestinal side effects, including diarrhea, loose stools, nausea, vomiting, and abdominal cramps. Ulcerative enterocolitis has also been reported, but this is rare. Orally and parenterally, gold salts may cause gold toxicity, with signs including aplastic anemia, low hemoglobin levels, leukopenia, granulocytopenia, immune thrombocytopenia, proteinuria, and hematuria (100534). Signs of liver injury and hepatotoxicity have also been reported, especially at higher doses (100535). Gold salts may also cause hypersensitivity (100536). Parenterally, gold salts commonly cause cutaneous reactions including pruritus and dermatitis. Chrysiasis may also occur (100534).
Dermatologic ...Parenterally, gold salts commonly cause cutaneous reactions including pruritus and dermatitis. Chrysiasis, which is an irreversible blue-gray discoloration of the skin, may also occur. Exposure to sunlight might worsen these reactions (100534). Sodium tetrachloroaurate is a gold salt and may theoretically cause similar adverse effects.
Gastrointestinal ...Orally, gold salts can cause stomatitis, which may be preceded by a metallic taste. Other adverse events including diarrhea, loose stools, nausea, vomiting, and abdominal cramps may also occur. Ulcerative enterocolitis has also been reported, but this is rare (100534). Sodium tetrachloroaurate is a gold salt and may theoretically cause similar adverse effects.
Hematologic ...Orally or parenterally, gold salts may cause gold toxicity, with signs including immune thrombocytopenia, leukopenia, granulocytopenia, and aplastic anemia (100534). Sodium tetrachloroaurate is a gold salt and may theoretically cause similar adverse effects.
Hepatic ...Orally and parenterally, gold salts have been associated with slight elevations in serum aminotransferase levels (100535). Parenterally, gold salts have also been associated with acute liver injury, although this is less common. Onset of injury seems to occur 1-8 weeks after starting therapy. Initial symptoms of liver injury include fever, rash, malaise, nausea, dark urine, and jaundice. Acute liver injury from gold therapy is typically associated with hypersensitivity. In rare cases, acute hepatocellular injury has been reported with high doses of gold salts (100535). Hepatic adverse effects have not been reported for sodium tetrachloroaurate; however, sodium tetrachloroaurate is a gold salt and may theoretically cause similar effects.
Immunologic ...Orally or parenterally, sodium tetrachloroaurate might cause adverse immune reactions. Gold (III) salts can cause oxidation of proteins, which may sensitize T cells and lead to hypersensitivity reactions (100536).
Renal ...Orally and parenterally, gold salts may cause nephrotic syndrome with proteinuria and hematuria. These adverse effects are typically mild, but may become severe and chronic if treatment is not discontinued after onset of the reaction (100534). Sodium tetrachloroaurate is a gold salt and may theoretically cause similar adverse effects.